Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-11-03
DOI: 10.1111/apt.71077 ↗At a glance
Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-11-03. Written by M F W Gee and 4 co-authors. Institution: Siemens Healthineers, Tarrytown, New York, USA. 9 references.
Abstract (original language)
Ebda abstract disponibbli.
Authors and institutions
- Siemens Healthineers, Tarrytown, New York, USA.
- Temerty Faculty of Medicine, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
- Division of Gastroenterology, Hepatology and Nutrition, Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
ORCID profiles: M F W Gee, E B De Vol, H R Levy, A T Boltyenkov, Sanyal Aj
Cite
APA
Gee, M. F. W., De Vol, E. B., Levy, H. R., Boltyenkov, A. T., & Aj, S. (2026). Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71077
Vancouver
Gee MFW, De Vol EB, Levy HR, Boltyenkov AT, Aj S. Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71077
BibTeX
@article{Gee2026,
author = {Gee, M F W and De Vol, E B and Levy, H R and Boltyenkov, A T and Aj, Sanyal},
title = {Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.71077}
}
EUVIMED